Brian Maurer
Foot & Ankle Surgery · Avon, CONPI 1912093071
Payments from drug & device makers
Across 61 payments — averaging $64.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$2K
- Kerecis Limited$1K
- Smith+Nephew$211
- Stryker$148
- Biopro, Inc.$104
- Amgen$67
- plus $543 from 16 others
What the payments were for
- Travel & lodging$2,07553%
- Food & beverage$1,75745%
- Gifts$952%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 13 | $1,780 |
| Kerecis Limited | 6 | $1,074 |
| Smith+Nephew | 10 | $211 |
| Stryker(2 entities) | 3 | $148 |
| Biopro, Inc. | 1 | $104 |
| Amgen | 5 | $67 |
| Tactile Systems Technology Inc | 4 | $67 |
| Flower Orthopedics Coporation | 2 | $63 |
| Ossio Inc | 1 | $62 |
| ANI Pharmaceuticals, Inc. | 2 | $53 |
| Gemini Mountain Medical, LLC | 1 | $42 |
| Organogenesis Inc. | 2 | $39 |
| Bioventus LLC | 1 | $37 |
| Integra Lifesciences Corporation | 2 | $31 |
| Convatec Inc. | 1 | $30 |
| Reddress USA, Inc. | 1 | $23 |
| Orthofix Medical, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Reprise Biomedical, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $15 |
| Arthrosurface Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$2,702
- LAPIPLASTY SYSTEM 1$880
- Kerecis GraftGuide$676
- Lapiplasty System$327
- Lapiplasty$138
How this compares
$3,928 in reported general payments places this provider in the 45th percentile of 181 foot & ankle surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 13 | $200 |
| Meloxicam | 52 | $156 |
| Methylprednisolone | 23 | $136 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $125 |
| Mupirocin | 11 | $103 |
| Cephalexin | 12 | $101 |
| Oxycodone Hcl | 11 | $38 |
| Tramadol Hcl | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Avon
- Michael HoughtonFort Collins$2M
- Joshua MetzlEnglewood$1.9M
- Thomas ClantonVail$1.6M
- Brad DresherColorado Springs$1.3M
- Brett SachsWheat Ridge$806K
- Jeffrey LehrmanFort Collins$629K
- Kevin NagamaniDenver$288K
- Keith JacobsonDenver$241K
- William MontrossColorado Springs$239K
- Dustin KruseWheat Ridge$221K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.